ÂÜÀòÂÒÂ×

Josh Halpern co-founded IntegriChain in 2006 and brings more than 20 years of experience in pharmaceutical commercialization, data, and analytics. As the company's Chief Executive Officer, he is responsible for corporate management and leadership of IntegriChain’s global workforce and strategic planning for the company, focusing on driving long-term business value across the company’s operations, its go-to-market strategy and teams, and its technology organization and roadmaps. From IntegriChain’s founding through its initial venture capital-backed growth, Halpern led the development of IntegriChain’s market leading channel and patient data aggregation solutions. Following the company’s partnership with Accel-KKR in 2016, Halpern has been a key leader in five successful acquisitions and their integration within the IntegriChain business and IntegriChain’s ICyte technology platform. In that time, IntegriChain has grown to become a visionary technology, data, consulting, and outsourcing platform for data-driven drug commercialization with more than 600 team members and 400 customers. Halpern is a frequent industry speaker and author on data-driven strategies for patient access and therapy commercialization. He earned his bachelor's degree at Princeton University.